Bacterial modification of taurocholate during enterohepatic recirculation in normal man and patients with small intestinal disease.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001419:Bacteria / Q000378:metabolism*; D001647:Bile Acids and Salts / Q000008:administration & dosage / Q000032:analysis / Q000378:metabolism*; D002247:Carbon Isotopes; D002845:Chromatography; D004378:Duodenal Diseases / Q000378:metabolism; D005260:Female; D006801:Humans; D007082:Ileum / Q000378:metabolism; D007408:Intestinal Absorption; D007410:Intestinal Diseases / Q000378:metabolism*; D007415:Intestinal Obstruction; D007583:Jejunum / Q000378:metabolism; D008102:Liver Circulation; D008297:Male; D008875:Middle Aged; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D013182:Sprue, Tropical / Q000378:metabolism; D013654:Taurine / Q000378:metabolism*; D008061:Whipple Disease / Q000378:metabolism
D001647:Bile Acids and Salts; D002247:Carbon Isotopes; D013654:Taurine; D006899:Mixed Function Oxygenases